|
1
|
Xu HZ, Liu YP, Guleng B and Ren JL:
Hepatitis B virus-related hepatocellular carcinoma: Pathogenic
mechanisms and novel therapeutic interventions. Gastrointest
Tumors. 1:135–145. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zampino R, Boemio A, Sagnelli C, Alessio
L, Adinolfi LE, Sagnelli E and Coppola N: Hepatitis B virus burden
in developing countries. World J Gastroenterol. 21:11941–11953.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
World Health Organization: Hepatitis B.
2018.
|
|
4
|
Zeng Z: Human genes involved in hepatitis
B virus infection. World J Gastroenterol. 20:7696–7706.
2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mathew S, Abdel-Hafiz H, Raza A, Fatima K
and Qadri I: Host nucleotide polymorphism in hepatitis B virus
associated hepatocellular carcinoma. World J Hepatol. 8:485–498.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu XW, Lu MH and Tan DM: Association
between tumour necrosis factor gene polymorphisms and the clinical
types of patients with chronic hepatitis B virus infection. Clin
Microbiol Infect. 11:52–56. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee
JH, Park CS, Lee JE, Hahm KB and Kim JH: Association between
chronic hepatitis B virus infection and interleukin-10, tumor
necrosis factor-α gene promoter polymorphisms. J Gastroenterol
Hepatol. 21:1163–1169. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hanafy SM and Abdo A: Impact of single
nucleotide polymorphism of TGF-β1 gene (SNP-Codon10) on
hepatocellular carcinoma risk in Egyptian patients following HCV
infection. Aust J Basic Appl Sci. 5:1814–1821. 2011.
|
|
9
|
Falleti E, Fabris C, Toniutto P, Fontanini
E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R and
Pirisi M: TGF-β1 genotypes in cirrhosis: Relationship with the
occurrence of liver cancer. Cytokine. 44:256–261. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schon H and Weiskirchen R:
Immunomodulatory effects of transforming growth factor-β in the
liver. Hepatobiliary Surg Nutr. 3:386–406. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hussain SP, Schwank J, Staib F, Wang XW
and Harris CC: TP53 mutations and hepatocellular carcinoma:
Insights into the etiology and pathogenesis of liver cancer.
Oncogene. 26:2166–2176. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang Z, Gou W, Liu M, Sang W, Chu H and
Zhang W: Expression of P53 and HSP70 in chronic hepatitis, liver
cirrhosis, and early and advanced hepatocellular carcinoma tissues
and their diagnostic value in hepatocellular carcinoma: An
immunohistochemical study. Med Sci Monit. 21:3209–3215.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gouas DA, Villar S, Ortiz-Cuaran S, Legros
P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, et al:
TP53 R249S mutation, genetic variations in HBX and risk of
hepatocellular carcinoma in The Gambia. Carcinogenesis.
33:1219–1224. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hu S, Zhao L, Yang J and Hu M: The
association between polymorphism of P53 Codon72 Arg/Pro and
hepatocellular carcinoma susceptibility: Evidence from a
meta-analysis of 15 studies with 3,704 cases. Tumor Biol.
35:3647–3656. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Baumert TF, Thimme R and von Weizsäcker F:
Pathogenesis of hepatitis B virus infection. World J Gastroenterol.
13:82–90. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
You CR, Lee SW, Jang JW and Yoon SK:
Update on hepatitis B virus infection. World J Gastroenterol.
20:13293–13305. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Geng M, Xin X, Bi LQ, Zhou LT and Liu XH:
Molecular mechanism of hepatitis B virus X protein function in
hepatocarcinogenesis. World J Gastroenterol. 21:10732–10738.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang ZH, Wu CC, Chen XW, Li X, Li J and
Lu MJ: Genetic variation of hepatitis B virus and its significance
for pathogenesis. World J Gastroenterol. 22:126–144.
2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guerrieri F, Belloni L, Pediconi N and
Levrero M: Molecular mechanisms of HBV-associated
hepatocarcinogenesis. Semin Liver Dis. 33:147–156. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ayub A, Ashfaq UA and Haque A: HBV induced
HCC: Major risk factors from genetic to molecular level. Biomed Res
Int. 2013(810461)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abe A, Kazuaki I, Take AT, Kato J,
Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M and Kohara M:
Quantification of hepatitis B virus genomic DNA by real-time
detection. J Clin Microbiol. 37:2899–2903. 1999.PubMed/NCBI
|
|
22
|
Jamil K, Jayaraman A, Ahmad J, Joshi S and
Yerra SK: TNF-alpha -308G/A and -238G/A polymorphisms and its
protein network associated with type 2 diabetes mellitus. Saudi J
Biol Sci. 24:1195–1203. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chou HT, Chen CH, Tsai CH and Tsai FJ:
Association between transforming growth factor-β1 gene C-509T and
T869C polymorphisms and rheumatic heart disease. Am Heart J.
148:181–186. 2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu X, Zhao H, Amos CI, Shete S, Makan N,
Hong WK, Kadlubar FF and Spitz MR: p53 genotypes and haplotypes
associated with lung cancer susceptibility and ethnicity. J Natl
Cancer Inst. 94:681–690. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee JH, Han KH, Lee JM, Park JH and Kim
HS: Impact of hepatitis B virus (HBV) X gene mutations on
hepatocellular carcinoma development in chronic HBV infection. Clin
Vaccine Immunol. 18:914–921. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nurainy N, Muljono DH, Sudoyo H and
Marzuki S: Genetic study of hepatitis B virus in Indonesia reveals
a new subgenotype of genotype B in east Nusa Tenggara. Arch Virol.
153:1057–1065. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nagasaki F, Niitsuma H, Cervantes JG,
Chiba M, Hong S, Ojima T, Ueno Y, Bondoc E, Kobayashi K, Ishii M
and Shimosegawa T: Analysis of the entire nucleotide sequence of
hepatitis B virus genotype B in the Philippines reveals a new
subgenotype of genotype B. J Gen Virol. 87:1175–1180.
2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Horikita M, Itoh S, Yamamoto K, Shibayama
T and Tsuda F: Differences in the entire nucleotide sequence
between hepatitis B virus genomes from carriers positive for
antibody to hepatitis B e antigen with and without active disease.
J Med Virol. 44:96–103. 1994.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim H, Lee SA and Kim BJ: X region
mutations of hepatitis B virus related to clinical severity. World
J Gastroenterol. 22:5467–5478. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Fan W, Shi B, Wei H, Du G and Song S:
Comparison of hepatitis B X gene mutation between patients with
hepatocellular carcinoma and patients with chronic hepatitis B.
Virus Genes. 42:162–170. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lin X, Xu X, Huang QL, Liu YQ, Zheng DL,
Chen WN and Lin JY: Biological impacts of ‘hot-spot’ mutations of
hepatitis B virus X proteins are genotype B and C differentiated.
World J Gastroenterol. 11:4703–4708. 2005.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fatimawali and Kepel B: Analisis
mutasi gen protein X virus HBV pada penderita hepatitis B akut di
manado. J LPPM Bid Sains Dan Teknol. 1:47–55. 2014.
|
|
33
|
Banday MZ, Balkhi HM, Hamid Z, Sameer AS,
Chowdri NA and Haq E: Tumor necrosis factor-α (TNF-α)-308G/A
promoter polymorphism in colorectal cancer in ethnic Kashmiri
population-A case control study in a detailed perspective. Meta
Gene. 9:128–136. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li X, Liang C, Parkman V and Lv Z: The
association between TNF-α 238A/G and 308A/G polymorphisms and
juvenile idiopathic arthritis. Medicine (Baltimore).
97(e12883)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Heidari Z, Moudi B, Mahmoudzadeh Sagheb H
and Moudi M: Association of TNF-α gene polymorphisms with
production of protein and susceptibility to chronic hepatitis B
infection in the South East Iranian population. Hepat Mon.
16(e41984)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin
ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, et al: Tumor
necrosis factor-α 308.2 polymorphism is associated with advanced
hepatic fibrosis and higher risk for hepatocellular carcinoma.
Neoplasia. 9:987–992. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tavakolpour S and Sali S: Tumor necrosis
factor-α-308 G/A polymorphisms and risk of hepatocellular
carcinoma: A meta-analysis. Hepat Mon. 16(e33537)2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xiao Q, Fu B, Chen P, Liu ZZ, Wang W and
Ye Q: Three polymorphisms of tumor necrosis factor-alpha and
hepatitis B virus related hepatocellular carcinoma: A
meta-analysis. Medicine (Baltimore). 95(e5609)2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Guo Y, Zang C, Li Y, Yuan L, Liu Q, Zhang
L and Li S: Association between TGF-β1 polymorphisms and
hepatocellular carcinoma risk: A meta-analysis. Genet Test Mol
Biomarkers. 17:814–820. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Qi P, Chen Y, Wang H, Fang M, Ji Q, Zhao
YP, Sun XJ, Liu Y and Gao CF: -509C>T polymorphism in the TGF-β1
gene promoter, impact on the hepatocellular carcinoma risk in
Chinese patients with chronic hepatitis B virus infection. Cancer
Immunol Immunother. 58:1433–1440. 2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Sümbül AT, Akkız H, Bayram S, Bekar A,
Akgöllü E and Sandıkçı M: p53 codon 72 polymorphism is associated
with susceptibility to hepatocellular carcinoma in the Turkish
population: A case-control study. Mol Biol Rep. 39:1639–1647.
2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cai J, Cai Y, Ma Q, Chang F, Xu L, Zhang G
and Guo X: Association of p53 codon 72 polymorphism with
susceptibility to hepatocellular carcinoma in a Chinese population
from northeast Sichuan. Biomed Rep. 6:217–222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tian X, Dai S, Sun J, Jiang S and Jiang Y:
Association between TP53 Arg72Pro polymorphism and leukemia risk: A
meta-analysis of 14 case-control studies. Sci Rep.
6(24097)2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
He T, Wu J, Chen Y and Zhang J: TP 53
polymorphisms and melanoma: A meta-analysis. J Cancer Res Ther.
11:409–414. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lin YM, Shao J, Yin XH, Huang C, Jia XW,
Yuan YD, Wu CJ, Zhen EM, Yao ZX, Zeng XT and Liu RH: Meta-analysis
results on the association between TP53 codon 72 polymorphism with
the susceptibility to oral cancer. Front Physiol.
9(1014)2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chachá SGF, Gomes-Gouvêa MS, Malta FM,
Ferreira SDC, Villanova MG, Souza FF, Teixeira AC2 Passos ADDC,
Pinho JRR and Martinelli ALC: Basal core promoter and precore
mutations among hepatitis B virus circulating in Brazil and its
association with severe forms of hepatic diseases. Mem Inst Oswaldo
Cruz. 112:626–631. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Al-qahtani AA, Al-anazi MR, Nazir N, Ghai
R, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan
MQ, et al: Hepatitis B virus (HBV) X gene mutations and their
association with liver disease progression in HBV-infected
patients. Oncotarget. 8:105115–105125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Datta S, Ghosh A, Dasgupta D, Ghosh A,
Roychoudhury S, Roy G, Das S, Das K, Gupta S, Basu K, et al: Novel
point and combo-mutations in the genome of hepatitis B
virus-genotype D: Characterization and impact on liver disease
progression to hepatocellular carcinoma. PLoS One.
9(e110012)2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Kim HJ, Park JH, Jee Y, Lee SA, Kim H,
Song BC, Yang S, Lee M, Yoon JH, Kim YJ, et al: Hepatitis B virus X
mutations occurring naturally associated with clinical severity of
liver disease among Korean patients with chronic genotype C
infection. J Med Virol. 80:1337–1343. 2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Li W, Goto K, Matsubara Y, Ito S, Muroyama
R, Li Q and Kato N: The characteristic changes in hepatitis B virus
X region for hepatocellular carcinoma: A comprehensive analysis
based on global data. PLoS One. 10(e0125555)2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wen J, Song C, Jiang D, Jin T, Dai J, Zhu
L, An J, Liu Y, Ma S, Qin N, et al: Hepatitis B virus genotype,
mutations, human leukocyte antigen polymorphisms and their
interactions in hepatocellular carcinoma: A multi-centre
case-control study. Nature. 5(16489)2015.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du
Y, Pu R, Han Y, Zhao J, Han X, et al: HLA-DP polymorphisms affect
the outcomes of chronic hepatitis B virus infections, possibly
through interacting with viral mutations. J Virol. 87:12176–12186.
2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Xie J, Zhang Y, Zhang Q, Han Y, Yin J, Pu
R, Shen Q, Lu W, Du Y, Zhao J, et al: Interaction of signal
transducer and activator of transcription 3 polymorphisms with
hepatitis B virus mutations in hepatocellular carcinoma.
Hepatology. 57:2369–2377. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ledesma MM, Galdame O, Bouzas B, Tadey L,
Livellara B, Giuliano S, Viaut M, Paz S, Fainboim H, Gadano A, et
al: Characterization of the basal core promoter and precore regions
in anti-HBe-positive inactive carriers of hepatitis B virus. Int J
Infect Dis. 15:e314–e320. 2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Chu CJ, Hussain M and Lok AS: Quantitative
serum HBV DNA levels during different stages of chronic hepatitis B
infection. Hepatology. 36:1408–1415. 2002.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Harkisoen S, Arends JE, van den Hoek JA,
Whelan J, van Erpecum KJ, Boland GJ and Hoepelman AI: Historic and
current hepatitis B viral DNA and quantitative HBsAg level are not
associated with cirrhosis in non-Asian women with chronic hepatitis
B. Int J Infect Dis. 29:133–138. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC,
Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS and Kao JH: High levels
of hepatitis B surface antigen increase risk of hepatocellular
carcinoma in patients with low HBV load. Gastroenterology.
142:1140–1149.e3. 2012.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Tu T, Budzinska MA, Shackel NA and Urban
S: HBV DNA integration: Molecular mechanisms and clinical
implications. Viruses. 9(E75)2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Leung NW, Tam JS, Lau GT, Leung TW, Lau WY
and Li AK: Hepatitis B virus DNA in peripheral blood leukocytes a
comparison between hepatocellular carcinoma and Other hepatitis B
virus-related chronic liver diseases. Cancer. 73:1143–1148.
1994.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Barbini L, Tadey L, Fernandez S, Bouzas B
and Campos R: Molecular characterization of hepatitis B virus X
gene in chronic hepatitis B patients. Virol J.
9(131)2012.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ghabeshi S, Sharifi Z, Hosseini SM and
Mahmoodian Shooshtari M: Correlation between viral load of HBV in
chronic hepatitis B patients and precore and basal core promoter
mutations. Hepat Mon. 13(e7415)2013.PubMed/NCBI View Article : Google Scholar
|
